Chargement en cours...
In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
The in vitro activity of BMY-28142 was compared with that of cefotaxime, ceftazidime, moxalactam, and imipenem against 639 clinical isolates and a number of in vitro-selected resistant mutants. BMY-28142 was the most potent compound against the members of the family Enterobacteriaceae with a MIC for...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1985
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180098/ https://ncbi.nlm.nih.gov/pubmed/3859244 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|